Main content
Course: MCAT > Unit 5
Lesson 16: Fat and protein metabolism- Fat and protein metabolism questions
- Glucogenic and ketogenic amino acids
- Introduction to energy storage
- Digestion, Mobilization, and Transport of Fats - Part I
- Digestion, Mobilization, and Transport of Fats - Part II
- Fatty Acid Synthesis - Part I
- Fatty Acid Synthesis - Part II
- Overview of Fatty Acid Oxidation
- Fatty Acid Oxidation - Part I
- Fatty Acid Oxidation - Part II
- How does the body adapt to starvation?
- Overview of Amino Acid Metabolism
© 2024 Khan AcademyTerms of usePrivacy PolicyCookie Notice
Fatty Acid Synthesis - Part I
Explore the fascinating process of fat metabolism, where triacylglycerides and free fatty acids journey from our diet, adipose cells, and liver into the bloodstream. Discover how these molecules provide cellular energy in the form of ATP, and delve into the intricate steps of fatty acid synthesis within liver cells. Created by Jasmine Rana.
Want to join the conversation?
- What is the point of breaking down TAG only to rebuild it in the SI and the liver?(6 votes)
- TAGs are broken down because they are too big to enter the cell by themselves. There are many processes in the cell that doesn't seem very efficient (like breaking down molecules to build them back up soon after), but it is the way our cells have evolved.(20 votes)
- What is the motivation for synthesizing fatty acids from glucose in the liver? I understand the fatty acids will be used for energy in cells throughout the body, so why wouldn't the liver just release glucose into the bloodstream instead?(5 votes)
- It is a way to store energy, as glycogen stores in our body are limited, and blood glucose concentrations are tightly controlled - whereas fat storage is virtually unlimited.(6 votes)
- I am very confused about10:08where the person says "citrate contains Aceyl CoA as well as oxaloacetate". I am pretty sure that is a false statement. CoA leaves in the condensation of Acetyl CoA with oxaloacetate in the first step of the krebs cycle.
Citrate is just a 6 carbon compound with zero CoA groups. How can it have a CoA group as a leaving group in the cytoplasm?
Thanks.(5 votes)- I think she just simplified the process for the sake of the video. You are correct that when acetyl-CoA and oxaloacetate combine to form citrate in the TCA cycle, the Coenzyme A is removed. Thus, once citrate is transported into the cytoplasm, another CoA must be added back into the equation during the ATP hydrolysis of citrate into oxaloacetate and acetyl-CoA.
Hope this helped!(7 votes)
- are the blood streams capable of creating their own fatty acids(1 vote)
- No, the bloodstream carries fatty acids but does not produce it itself. Fatty acids in the bloodstream come from your diet, adipose tissue, and liver (via synthesis from glucose). The synthesis of fatty acids from glucose occurs within liver cells' cytoplasm, which is the internal part of the cell.(10 votes)
- what enzyme converts OAA to pyruvate producing an NADPH? I know malate can be converted to pyruvate producing NADPH via malic enzyme.(3 votes)
- Is there a difference between VLDL and LDL?(3 votes)
- VLDL stands for 'Very Low Density Lipoprotein'. It contains less apoprotein, more triglycerides, and can be thought of as a way in which the body transports fats (similar to a chylomicron). LDL stands for "Low Density Lipoprotein'. Density refers to the amount of protein in the lipoprotein, so LDL contains more protein. It aslo contains a smaller proportion of triglycerides and a larger proportion of cholesterol. LDL is associated with athrosclerosis and arterial plaque leading to cardiovascular disease - so it's sometimes known as the 'bad cholesterol' (even though its a complex of all sorts of things- not just cholesterol).(5 votes)
- Why are the TAGs packaged into VLDLs before entering the bloodstream, rather than LDLs?(2 votes)
- TAGs are packaged up into VLDLs first and then exported out of the liver and into the bloodstream. Here, the VLDLs are converted to LDLs by enzymes via an intermediate stage (fittingly called IDLs). this process actually has various stages as certain bits/subunits of the lipoprotein are removed. VLDL starts with apolipoprotein B100, apolipoprotein C1 (apoC1), apolipoprotein E (apoE), cholesterol, cholestryl esters, and triglycerides and gradually loses bits. this changes its composition such that different receptors pick it up as a signal differently, which is a way for the body to be able to "track" its progress as it travels through the body gradually transitioning to an LDL. this has obvious advantages allowing different tissues to deal with contents of these lipoproteins more appropriately.(3 votes)
- Is pyruvate dehydrogenase embedded within the membrane of the mitochondria, or found in the mitochondrial matrix. If it is found in the mitochondrial matrix, how does it enter the mitochondria?(3 votes)
- Is the liver the only organ where fatty acid synthesis can occur?(2 votes)
- In the mitochondria, is pyruvate cleaved into acetyl CoA and acetyl CoA combines with free OAA to form citrate, or is pyruvate cleaved into both acetyl CoA and OAA? I have learned the latter in classes but i want to double check.(2 votes)
- Pyruvate actually combines with OAA to make citrate. At the end of the cycle, OAA is regenerated after a couple of carbons have been lost as CO2.(1 vote)
Video transcript
- [Instructor] Now the
ultimate goal in fat metabolism is to be able to deliver
some triacylglycerides, which I'm gonna abbreviate here at TAG, which remember is the chemical
name for a fat molecule, or free fatty acids, which I'll abbreviate here at FFA, which if you recall are the
kind of monomer subunits of these fat molecules
directly into the bloodstream where they can eventually
reach capillary beds like the one that I've drawn here. So I'll go ahead and label
this as a capillary bed, and it's important that they
reach these capillary beds because it's at this point
where they can diffuse to surrounding tissues such
as muscle or heart tissue, for example, where they can
be taken up by these tissues and oxidized to obtain cellular
energy in the form of ATP. Now I want to remind you that there are three main sources of
these triacylglycerides or free fatty acids that
can enter the bloodstream, and so I'm gonna go
ahead and scroll up here and show you kind of what
I've already drawn out here and go ahead and explain it. Starting off here on the far left I've drawn a cheeseburger, perhaps not the best drawing in the world, but just to remind us that
one of our sources of fat that ultimately reaches our bloodstream is directly from our diet. So recall that our small intestine digests our food and
packages the fat molecules, the triacylglycerides, into protein carrier
molecules called chylomicrons, which travel through the
lymphatic circulation but eventually empty into our bloodstream where they can enter capillary beds. Now the second way that we can get some fat into our bloodstream is directly from adipose cells. So recall that adipose cells are specialized cells inside of our body that can store large amounts of fat, and so that's kind of what I've drawn here in these yellow circles
within these cells, these large fatty droplets. And several hours after a meal, when your hormone insulin begins
to drop inside of your body and other hormones such
as glucagon begin to rise, they signal these adipose cells to release free fatty acids directly into the bloodstream, and recall that free fatty
acids are very hydrophobic, so they kind of surf, essentially they kind of attach themselves onto albumin molecules, which is a special type of protein that's always found
inside of our bloodstream. Now the third way that we can get some fat into our bloodstream is by synthesizing it directly inside of the liver, which I've kind of drawn
an outline of here. Now the liver cells
are especially equipped with the right type and number of enzymes to be able to convert excess glucose, that is the glucose that's not being used for ATP synthesis or glycogen synthesis, into fatty acids. Then, like the small intestine, the liver essentially
packages these fatty acids into triacylglyceride molecules and packages them
together with cholesterol, another hydrophobic molecule, into another specialized
protein carrier molecule like chylomicrons, but this one has a slightly different name. It's called very low density lipoprotein, or VLDL for short. And this of course is sent
off to the bloodstream, where it will eventually
reach capillary beds and be taken up by surrounding tissues, even perhaps adipose cells, which might store it up for later use. So now that we've gone over this overview, I want to zoom in on one of these steps. I want to zoom in on this step here, going from glucose to fatty
acids inside of the liver, which is commonly referred to simply as fatty acid synthesis. And to do this, I want to go ahead and
kind of just zoom in on one single cell inside of the liver to visualize what's going
on at the cellular level to be able to allow us to convert
glucose into a fatty acid. And so I'm gonna go ahead
and scroll the screen here so we can have some more room. All right, so I'm gonna quickly draw an outline of a representative cell, and then we'll go ahead and quickly label some important compartments
that we want to talk about. So the first one is simply the cytoplasm, and there's a lot going
on in the cytoplasm. But we also need to talk about what's going on in another
organelle inside the cell, and that organelle is the mitochondria, and I'm gonna go ahead and
draw the kind of two membranes that it has here. We're not gonna talk about this too much, but just because it is
important to remember that this has an inner
membrane and an outer membrane. Remember that the electron transport chain is of course located
on the inner membrane, and the mitochondria is also within it. It's the site of the Krebs cycle, which continues, notably, to break down glucose
following glycolysis, which takes place inside of the cytoplasm. Now since we ultimately want to get down to how extra glucose can be eventually converted into fatty acids, we need to actually make
sure and remind ourselves how the breakdown of glucose proceeds. So as a very, very quick review, recall that glucose enters
our cells from the bloodstream and it enters the metabolic
pathway called glycolysis, which takes place inside the cytoplasm. And the end product of
glycolysis is pyruvate, and I'll also remind you that for every one molecule of glucose, which is a six-carbon molecule, so one, two, three, four, five, six, we form two molecules of pyruvate, which is a three-carbon compound. Subsequently, pyruvate
is actively transported across the mitochondrial membrane by specialized carrier proteins
located on the membrane, and once pyruvate reaches the
inside of the mitochondria, also known as the inner
mitochondrial matrix, there is a enzyme that's only found in the mitochondria called
pyruvate dehydrogenase, often abbreviated as PDH, which oxidizes and removes
one carbon from pyruvate. So remember, we had three carbons, and now it turns it into
a two-carbon molecule called acetyl-CoA. Now you might recall that
this two-carbon structure is not done being broken down or oxidized. There's still some energy
that we can extract from this two-carbon molecule, and it's extracted inside
of the Krebs cycle. So remember that there are
many, many intermediates along the Krebs cycle, but I only want to mention a couple that will be relevant when we talk about how this breakdown of glucose converges with the
synthesis of fatty acids. So remember first off that
a four-carbon molecule called oxaloacetoacetate, which I'm abbreviating here as OAA, combines with one molecule of acetyl-CoA to produce a sixth carbon
molecule now called citrate. And citrate continues to be modified, oxidized, and even broken
down a little bit more, and it returns to form oxaloacetate, which means that we lose two carbons somewhere along this cycle, which we do indeed. We lose these as two
molecules of carbon dioxide, so those two carbons of
acetyl-CoA exit as carbon dioxide, and we also form a number of reduced electron carrier molecules
called NADH and FADH2, which shuttle their electrons
from the oxidation process that occurs in the Krebs cycle to the electron transport chain, which is located on this
inner mitochondrial membrane. How convenient, right? And then from there, we can produce ATP using
oxidated phosphorylation. All right, so after that
quick whirlwind tour of the breakdown of glucose, you might be wondering where do we convert glucose into fatty acids? And it turns out that
one of the intermediates of the breakdown of glucose, which is acetyl-CoA,
this two carbon molecule located in the mitochondrial inner matrix, is a precursor for fatty acid synthesis, and we're gonna go
through all of the steps, but just to take a step back for a moment, the big picture way that I kind
of like to think about this is that remember that fatty acids, I'm gonna go ahead and
draw off to the side here, remember that most of it is just a repeating
carbon hydrogen backbone shown here in this kind
of line stick model here. And so in that sense, really we want to basically be able to link together carbon-carbon bonds, and this acetyl-CoA is just
a pair of carbon-carbon bonds that we can ultimately link together. Now it turns out that we
have an interesting situation when it comes to fatty acid synthesis and linking all of these
acetyl-CoA molecules together, which is that all of the enzymes necessary for fatty acid synthesis, I'm gonna say enzymes
for fatty acid synthesis, are located in the cytoplasm. And that's a bit problematic, because remember our acetyl-CoA molecule is in the mitochondria. Now your first thought might be, well, pyruvate was able to shuttle across using some protein career
molecules in these membranes into the mitochondria. Why can't acetyl-CoA do the same going the opposite direction? Unfortunately, for some
reason or the other, our body has evolved not to have any means to be able to transport this through its mitochondrial membrane. There are no protein
transporters or carrier molecules like we had for pyruvate to be able to essentially shuttle
acetyl-CoA in either direction across this mitochondrial membrane. But notably, our body does
have a protein shuttle across this mitochondrial
membrane for the molecule citrate, and remember that citrate
contains acetyl-CoA. Of course, it also contains
this molecule acetylacetate that combines with it. And so let's see what happens when this shuttles across
the mitochondrial membrane. Now once citrate reaches the cytoplasm, it turns out that there is an enzyme within the cytoplasm that is able to break citrate up back into oxaloacetate, as well as the molecule
that we're interested in, which is of course acetyl-CoA. Now when I first learned about this, it kind of struck me as
a really roundabout way to kind of accomplish what seems like a pretty simple task, right, which is to get acetyl-CoA
into the cytoplasm where the enzymes or fatty acid synthesis can link it together to form a fatty acid. But it turns out that
there might be a benefit for this citrate shuttle to
make fatty acid synthesis perhaps more efficient, and so I want to briefly talk about that, but I want to erase this just
to give us some more room. Now it turns out that
this four-carbon molecule, oxaloacetate, is not going to be used for fatty acid synthesis. And so naturally our body
says why don't we recycle it? And in fact, we do have some enzymes that can convert it back
to this molecule pyruvate, and notice that pyruvate can essentially, once it goes back to the mitochondria, it'll be turned into acetyl-CoA and this entire cycle can continue. Now although we're not gonna go over the detailed mechanism
by which oxaloacetate is converted to pyruvate, what is important, kind of a
big picture idea to note here, is that we're going from a four-carbon to three-carbon molecule, and so we're gonna lose
a carbon, actually, as carbon dioxide during this process. And simultaneous with this step, we're actually oxidizing
that particular intermediate. And so when we oxidize something, we're able to reduce something else, and it turns out that what
we reduce in this case is a molecule of NAD+. And so it's reduced to NADPH, and you may recall that
you've seen NADPH also as a product of the
pentose phosphate pathway, and of course we normally think about the pentose phosphate pathway
as being the major pathway for the production of NADPH, but this step also allows us to produce a molecule of NADPH as well. Now one of the uses of
NADPH that you might recall is that because it's associated
with these electrons, it can serve as a source of reducing power to help with anabolic reactions. And remember that anabolic reactions are anything that involve
building up a molecule, including fatty acid synthesis, which is exactly what we're
trying to accomplish here. So to summarize and just kind of tie up everything that we've
just talked about here, we've been able to get
acetyl-CoA into the cytoplasm where all of the enzymes necessary for fatty acid synthesis are located. And this is important because
we're gonna use acetyl-CoA, multiple acetyl-CoA, kind
of a precursor molecule, so to say, to build up a fatty acid. And of course because this
is an anabolic reaction, we're going to need some
ATP somewhere along the way, and we're also going to
need some reducing power to kind of help form all of
those carbon-carbon bonds, and we can get that using NADPH. Of course, NADPH can be supplied by the pentose phosphate pathway, but conveniently, perhaps, by using this citrate shuttle, we're also able to produce
a molecule of NADPH from the conversion of
oxaloacetate into pyruvate. In the next video, we'll pick up right here in the cytoplasm to talk about how this conversion from acetyl-CoA into a fatty acid occurs.